Observational Study of How Patients Take Eye Drops
- Conditions
- Glaucoma
- Registration Number
- NCT00750646
- Lead Sponsor
- Robin, Alan L., M.D.
- Brief Summary
This study is interested in monitoring how patients take eye drops, both through video-recordings and adherence monitoring, as well as their perceptions about their eye medications; including the dosing schedules, instillation techniques and effect on their disease.
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- UNKNOWN
- Sex
- All
- Target Recruitment
- 220
Inclusion Criteria
- >18 year old
- currently taking 1 or more hypotensive topical eye drops takes drops in the right eye for more than 6 months expect to continue drop use for the next 3 months
- subjects instill their own eye drops
- subject is able to take HVF tests
- subject will expect to complete the 3 months enrollment period
Exclusion Criteria
- unable/unwilling to instill own medications
- eye drops are discontinued
- unable to take HVF test
- unable to complete follow-up
- investigators discontinue subject for safety reasons
- not using drops in left eye
Study & Design
- Study Type
- OBSERVATIONAL
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Medication adherence measured by MEMS caps 3 months Eye drop technique measured by video evaluation 1 time observation
- Secondary Outcome Measures
Name Time Method Medication adherence measured by self-report 3 months Severity of VF damage 1 test date Intraocular pressure readings 3 months
Related Research Topics
Explore scientific publications, clinical data analysis, treatment approaches, and expert-compiled information related to the mechanisms and outcomes of this trial. Click any topic for comprehensive research insights.
What molecular mechanisms underlie glaucoma medication adherence using MEMS caps in NCT00750646?
How does MEMS cap technology compare to standard-of-care adherence monitoring in glaucoma treatment?
Are there specific biomarkers associated with improved adherence to eye drop therapy in glaucoma patients?
What adverse events are commonly reported with glaucoma eye drop regimens and how can they be mitigated?
What combination therapies with MEMS caps show enhanced IOP control compared to monotherapy in glaucoma?
Trial Locations
- Locations (1)
Glaucoma Specialists
🇺🇸Baltimore, Maryland, United States
Glaucoma Specialists🇺🇸Baltimore, Maryland, United StatesColleen K ProtzkoContact410-377-2422cprotzko@glaucomaexpert.comMillie BrummettContact4103772422Jennifer L Stone, ODPrincipal InvestigatorAlan L Robin, MDSub Investigator